Please enable JavaScript to continue using this application.

Compare $CGON vs $MIRM | Chartloom

Compare

$CGON vs $MIRM

CG Oncology Inc · Mirum Pharmaceuticals Inc

CGON

CG Oncology Inc

MIRM

Mirum Pharmaceuticals Inc

Compare $CGON vs $MIRM

Comparing CG Oncology Inc and Mirum Pharmaceuticals Inc

CGONCG Oncology Inc

MIRMMirum Pharmaceuticals Inc

CGONCG Oncology Inc

Market cap

$5.63B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

135.78x

Rev growth (TTM)

1030.3%

YTD performance

52.7%

52W performance

56.8%

FCF yield

-3.2%

MIRMMirum Pharmaceuticals Inc

Market cap

$5.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.85x

Rev growth (TTM)

44.0%

YTD performance

10.2%

52W performance

18.1%

FCF yield

-5.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CGON

MIRM

Detailed metrics comparison

CGON

CG Oncology Inc

MIRM

Mirum Pharmaceuticals Inc

Market Cap

CGON$5.63B

MIRM$5.24B

Enterprise Value

CGON$5.61B

MIRM$5.66B

Price

CGON$63.82

MIRM$86.01

P/E Ratio

CGONN/A

MIRMN/A

P/S Ratio

CGON903.81x

MIRM8.49x

EV/Sales

CGON901.14x

MIRM9.16x

EV/EBITDA

CGON0.00x

MIRM2,753.41x

P/B Ratio

CGON5.80x

MIRM22.21x

P/FCF Ratio

CGONN/A

MIRMN/A

EV/FCF

CGON-31.29x

MIRM-21.48x

PEG Ratio

CGONN/A

MIRMN/A

Forward P/E (NTM)

CGONN/A

MIRMN/A

Forward P/S (NTM)

CGON135.78x

MIRM6.85x

Revenue (TTM)

CGON$6M

MIRM$618M

Revenue Growth (YoY)

CGON1030.3%

MIRM44.0%

Forward Rev Growth

CGON1916.0%

MIRM17.0%

Gross Margin (TTM)

CGON-85.2%

MIRM81.7%

Operating Margin (TTM)

CGON0.0%

MIRM0.0%

EBITDA Margin (TTM)

CGON-4008.7%

MIRM-10.6%

Net Margin (TTM)

CGON-3602.7%

MIRM-139.2%

FCF Margin (TTM)

CGON-2879.6%

MIRM-42.7%

Net Income (TTM)

CGON$-224M

MIRM$-860M

FCF (TTM)

CGON$-179M

MIRM$-264M

EPS (TTM)

CGON-$2.54

MIRM-$13.57

ROE (TTM)

CGON-2520.0%

MIRM-28933.0%

ROA (TTM)

CGON-2398.0%

MIRM-9655.0%

ROIC (TTM)

CGON-2512.0%

MIRM-13639.0%

Cash

CGON$20M

MIRM$331M

Debt

CGON$3M

MIRM$750M

Net Cash/Debt

CGON$17M

MIRM$-419M

Current Ratio (TTM)

CGON22.22x

MIRM2.86x

Quick Ratio (TTM)

CGON21.78x

MIRM2.62x

Debt/Equity (TTM)

CGON0.00x

MIRM1.28x

Debt/Assets (TTM)

CGON0.0%

MIRM0.0%

Interest Coverage (TTM)

CGONN/A

MIRMN/A

Net Debt/EBITDA (TTM)

CGON0.00x

MIRM0.00x

Beta

CGON0.25

MIRM0.75

52W Performance

CGON56.8%

MIRM18.1%

YTD Performance

CGON52.7%

MIRM10.2%

% from 52W High

CGON-21.2%

MIRM-33.8%

% from 52W Low

CGON78.3%

MIRM36.0%

Asset Turnover (TTM)

CGON0.01x

MIRM0.69x

FCF Yield (TTM)

CGON-3.2%

MIRM-5.0%

Earnings Yield (TTM)

CGON-4.0%

MIRM-16.4%

Dividend Yield (TTM)

CGONN/A

MIRMN/A

Rule of 40

CGON-1,849.3

MIRM1.3

EV/GP/RG

CGONN/A

MIRM0.45

Ticker research

View CGON research View MIRM research

Metric	CGON CG Oncology Inc	MIRM Mirum Pharmaceuticals Inc
Market & Valuation
Market Cap	$5.63B	$5.24B
Enterprise Value	$5.61B	$5.66B
Price	$63.82	$86.01
P/E Ratio	N/A	N/A
P/S Ratio	903.81x	8.49x
EV/Sales	901.14x	9.16x
EV/EBITDA	0.00x	2,753.41x
P/B Ratio	5.80x	22.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-31.29x	-21.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	135.78x	6.85x
Revenue & Growth
Revenue (TTM)	$6M	$618M
Revenue Growth (YoY)	1030.3%	44.0%
Forward Rev Growth	1916.0%	17.0%
Profitability
Gross Margin (TTM)	-85.2%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4008.7%	-10.6%
Net Margin (TTM)	-3602.7%	-139.2%
FCF Margin (TTM)	-2879.6%	-42.7%
Net Income (TTM)	$-224M	$-860M
FCF (TTM)	$-179M	$-264M
EPS (TTM)	-$2.54	-$13.57
ROE (TTM)	-2520.0%	-28933.0%
ROA (TTM)	-2398.0%	-9655.0%
ROIC (TTM)	-2512.0%	-13639.0%
Financial Health
Cash	$20M	$331M
Debt	$3M	$750M
Net Cash/Debt	$17M	$-419M
Current Ratio (TTM)	22.22x	2.86x
Quick Ratio (TTM)	21.78x	2.62x
Debt/Equity (TTM)	0.00x	1.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.25	0.75
52W Performance	56.8%	18.1%
YTD Performance	52.7%	10.2%
% from 52W High	-21.2%	-33.8%
% from 52W Low	78.3%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.69x
FCF Yield (TTM)	-3.2%	-5.0%
Earnings Yield (TTM)	-4.0%	-16.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,849.3	1.3
EV/GP/RG	N/A	0.45
Ticker research	View CGON research	View MIRM research

Valuation

P/S Ratio

MIRM

8.49x

CGON

903.81x

EV/FCF

CGON

-31.29x

MIRM

-21.48x

Growth & revenue

Revenue Growth TTM

CGON

1030.3%

MIRM

44.0%

Forward Revenue Growth

CGON

1916.0%

MIRM

17.0%

Profitability & performance

Gross Margin

MIRM

81.7%

CGON

-85.2%

ROE

CGON

-2520.0%

MIRM

-28933.0%

FCF Yield %

CGON

-3.2%

MIRM

-5.0%

52-Week Performance

CGON

56.8%

MIRM

18.1%

Detailed metrics comparison

CGON

CG Oncology Inc

MIRM

Mirum Pharmaceuticals Inc

Market Cap

CGON$5.63B

MIRM$5.24B

Enterprise Value

CGON$5.61B

MIRM$5.66B

Price

CGON$63.82

MIRM$86.01

P/E Ratio

CGONN/A

MIRMN/A

P/S Ratio

CGON903.81x

MIRM8.49x

EV/Sales

CGON901.14x

MIRM9.16x

EV/EBITDA

CGON0.00x

MIRM2,753.41x

P/B Ratio

CGON5.80x

MIRM22.21x

P/FCF Ratio

CGONN/A

MIRMN/A

EV/FCF

CGON-31.29x

MIRM-21.48x

PEG Ratio

CGONN/A

MIRMN/A

Forward P/E (NTM)

CGONN/A

MIRMN/A

Forward P/S (NTM)

CGON135.78x

MIRM6.85x

Revenue (TTM)

CGON$6M

MIRM$618M

Revenue Growth (YoY)

CGON1030.3%

MIRM44.0%

Forward Rev Growth

CGON1916.0%

MIRM17.0%

Gross Margin (TTM)

CGON-85.2%

MIRM81.7%

Operating Margin (TTM)

CGON0.0%

MIRM0.0%

EBITDA Margin (TTM)

CGON-4008.7%

MIRM-10.6%

Net Margin (TTM)

CGON-3602.7%

MIRM-139.2%

FCF Margin (TTM)

CGON-2879.6%

MIRM-42.7%

Net Income (TTM)

CGON$-224M

MIRM$-860M

FCF (TTM)

CGON$-179M

MIRM$-264M

EPS (TTM)

CGON-$2.54

MIRM-$13.57

ROE (TTM)

CGON-2520.0%

MIRM-28933.0%

ROA (TTM)

CGON-2398.0%

MIRM-9655.0%

ROIC (TTM)

CGON-2512.0%

MIRM-13639.0%

Cash

CGON$20M

MIRM$331M

Debt

CGON$3M

MIRM$750M

Net Cash/Debt

CGON$17M

MIRM$-419M

Current Ratio (TTM)

CGON22.22x

MIRM2.86x

Quick Ratio (TTM)

CGON21.78x

MIRM2.62x

Debt/Equity (TTM)

CGON0.00x

MIRM1.28x

Debt/Assets (TTM)

CGON0.0%

MIRM0.0%

Interest Coverage (TTM)

CGONN/A

MIRMN/A

Net Debt/EBITDA (TTM)

CGON0.00x

MIRM0.00x

Beta

CGON0.25

MIRM0.75

52W Performance

CGON56.8%

MIRM18.1%

YTD Performance

CGON52.7%

MIRM10.2%

% from 52W High

CGON-21.2%

MIRM-33.8%

% from 52W Low

CGON78.3%

MIRM36.0%

Asset Turnover (TTM)

CGON0.01x

MIRM0.69x

FCF Yield (TTM)

CGON-3.2%

MIRM-5.0%

Earnings Yield (TTM)

CGON-4.0%

MIRM-16.4%

Dividend Yield (TTM)

CGONN/A

MIRMN/A

Rule of 40

CGON-1,849.3

MIRM1.3

EV/GP/RG

CGONN/A

MIRM0.45

Ticker research

View CGON research View MIRM research

Metric	CGON CG Oncology Inc	MIRM Mirum Pharmaceuticals Inc
Market & Valuation
Market Cap	$5.63B	$5.24B
Enterprise Value	$5.61B	$5.66B
Price	$63.82	$86.01
P/E Ratio	N/A	N/A
P/S Ratio	903.81x	8.49x
EV/Sales	901.14x	9.16x
EV/EBITDA	0.00x	2,753.41x
P/B Ratio	5.80x	22.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-31.29x	-21.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	135.78x	6.85x
Revenue & Growth
Revenue (TTM)	$6M	$618M
Revenue Growth (YoY)	1030.3%	44.0%
Forward Rev Growth	1916.0%	17.0%
Profitability
Gross Margin (TTM)	-85.2%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4008.7%	-10.6%
Net Margin (TTM)	-3602.7%	-139.2%
FCF Margin (TTM)	-2879.6%	-42.7%
Net Income (TTM)	$-224M	$-860M
FCF (TTM)	$-179M	$-264M
EPS (TTM)	-$2.54	-$13.57
ROE (TTM)	-2520.0%	-28933.0%
ROA (TTM)	-2398.0%	-9655.0%
ROIC (TTM)	-2512.0%	-13639.0%
Financial Health
Cash	$20M	$331M
Debt	$3M	$750M
Net Cash/Debt	$17M	$-419M
Current Ratio (TTM)	22.22x	2.86x
Quick Ratio (TTM)	21.78x	2.62x
Debt/Equity (TTM)	0.00x	1.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.25	0.75
52W Performance	56.8%	18.1%
YTD Performance	52.7%	10.2%
% from 52W High	-21.2%	-33.8%
% from 52W Low	78.3%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.69x
FCF Yield (TTM)	-3.2%	-5.0%
Earnings Yield (TTM)	-4.0%	-16.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,849.3	1.3
EV/GP/RG	N/A	0.45
Ticker research	View CGON research	View MIRM research